Anna Sureda is a clinical haematologist internationally recognized for her expertise in haematopoietic stem cell transplantation and cellular therapies. She is Head of the Haematology Department at the Institut Català d’Oncologia (ICO) in L’Hospitalet, Barcelona, Spain, and Associate Professor of Haematology at the University of Barcelona. Her clinical and research interests focus on lymphoid malignancies, particularly Hodgkin and non-Hodgkin lymphomas, using innovative transplant strategies and immunotherapeutic approaches, including CAR-T cell therapy. She has contributed significantly to advances in supportive care and the management of transplant-related complications. She is currently President of EBMT until 2026, having previously served as EBMT Secretary (2010–2016) and Chair of the Lymphoma Working Party (2004–2010).

‍